Abstract
• There are scarcity of data about the use of T and B lymphocytes as biomarkers for the outcome of patients with colorectal cancer. • It was performed the staining of T and B lymphocytes subsets in the peripheral blood of patients with colorectal cancer and these findings were correlated with the patients outcome. • Two patients with disease relapse after CRC treatment presented higher percentages of B double negative lymphocytes.